References
- Sipponen P, Varis K, Fräki O, Korri U M, Seppälä K, Siurala M. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 outpatients. Scand J Gastroenterol 1990; 25: 966–73
- Malfertheiner P, Halter F. Peptic ulcer pathogenesis. The year in Helicobacter pylori 1994, P Malfertheiner, F Mégraud, P Michetti, A Price. Current Science, London 1994; 30–4
- Borody T J, George L L, Brandl S, Andrews P, Ostapowicz N, Hyland L, et al. Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol 1991; 86: 1154–7
- Bell G D, Powell K U. Eradication of Helicobacter pylori and its effect in peptic ulcer disease. Scand J Gastroenterol 1993; 196(28 Suppl)7–11
- Mohamed A H, Wilkinson J, Hunt R H. Duodenal ulcer recurrence after Helicobacter pylori (Hp) eradication: a meta-analysis. Gastroenterology 1994; 106: A142
- Labenz J, Borsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55: 19–23
- Blaser M J. Helicobacter pylori phenotypes associated with peptic ulceration. Scand J Gastroenterol 1994; 205(29 Suppl)1–5
- Crabtree J E, El-Omar E, Bugnoli M, Covacci A, Eyre D, Rappuoli R, et al. Serum CagA IgG antibodies in Helicobacter pylori positive healthy volunteers and patients with dyspeptic disease. Gut 1994; 35(Suppl 2)S35
- Borody T J, George L L, Brandl S, Andrews P, Jankiewicz E, Ostapowicz N. Smoking does not contribute to duodenal ulcer relapse after Helicobacter pylori eradication. Am J Gastroenterol 1992; 87: 1390–3
- Cullen D JE, Hawkey G M, Humphries H, Cave R, Shepherd V, Logan R FA, et al. Role of non-steroidal anti-inflammatory drugs and Helicobacter pylori in bleeding peptic ulcer. Gastroenterology 1994; 106: A66
- Hamlet A, Olbe L. Aspirin and Helicobacter pylori both block reflex pathways for inhibition of gastric acid secretion. Gastroenterology 1994; 106: A88
- Reinbach D H, Cruickshank G, McColl K EL. Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut 1993; 34: 1344–7
- Kawai K, Shirakawa K, Misaki F, Hayashi K, Watanabe Y. Natural history and epidemiologic studies of peptic ulcer disease in Japan. Gastroenterology 1989; 96(Suppl)581–5
- Asaka M. Gastric mucosal infection with Helicobacter pylori. Gastrointest Res 1994; 2: 7–15
- Aoyama N, Nakashima T. Eradication of Helicobacter pylori in gastric ulcer and relapse. Naika 1994; 73: 476–80
- Labenz J, Borsch G. Change of the natural history of peptic ulcer disease after cure of Helicobacter pylori infection. A prospective long-term study. Am J Gastroenterol 1994; 89: 1376
- Hirschl A M, Schütze K, Hentschel E, Gragosics B. Serological, microbiological and clinical results of a 43 months follow-up after successful eradication of H. pylori in duodenal ulcer patients. Am J Gastroenterol 1994; 89: 1374
- Haruma K, Kawaguchi H, Kohmoto K, Tanaka S, Tsuda T, Takehara Y, et al. Reduced incidence of Helicobacter pylori infection in Japan during the last 10 years. Gastroenterology 1994; 106: A91
- Kohmoto K, Haruma K, Kawaguchi H, Okamoto S, Uemura N, Teixeira C R, et al. Helicobacter pylori infection in young Japanese patients is a major risk factor for gastric carcinoma. Gastroenterology 1994; 106: A109
- Heatley R V. Review article: the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1992; 6: 291–303
- Axon A TR. Helicobacter pylori therapy: effect on peptic ulcer disease. J Gastroenterol Hepatol 1991; 6: 131–7
- Labenz J, Ruhl G H, Stolte M, Bertrams J, Borsch G. Efficacy of low-dose one-week triple therapy to cure H. pylori infection. Am J Gastroenterol 1994; 89: 1376
- Goddard A, Logan R. One-week low-dose triple therapy: new standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 1995; 7: 1–3
- NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65–9